首页> 外文学位 >Properties of polymeric drug delivery systems prepared by hot-melt extrusion.
【24h】

Properties of polymeric drug delivery systems prepared by hot-melt extrusion.

机译:通过热熔挤出制备的聚合物药物递送系统的性质。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this research project was to investigate the physicochemical and drug release properties of polymeric drug delivery systems prepared by hot-melt extrusion containing either highly water-soluble drugs or a poorly water-soluble drug. The properties of processed materials were characterized by thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), stability indicating RP-HPLC assay, dissolution studies, scanning electron microscopy (SEM), X-ray diffractometry, electronic torque rheometry, Zeta potential particle size analysis, and helium pycnometry.; Chlorpheniramine maleate (CPM), diltiazem hydrochloride (DTZ), indomethacin (IDM), and the excipients were thermally and chemically stable following hot-melt extrusion. CPM decreased the glass transition temperature (Tg) of EudragitRTM RS PO and exhibited a solid-state plasticization effect. CPM and IDM were in the amorphous state and DTZ was in the crystalline state following hot-melt extrusion processing. Triethyl citrate (TEC) facilitated the hot-melt extrusion process by decreasing the Tg and the melt viscosity of EudragitRTM RS PO. However, the thermal lubricant, glyceryl monostearate (GMS), only decreased the melt viscosity of the Eudragit RTM RS PO. The CPM release rate constant decreased in the order from tablets prepared by direct compression, hot-melt granulation, and hot-melt extrusion. This was due to an increase in the intermolecular binding and entanglement between drug molecules and polymer molecules that occurred during thermal processing. Post-processing thermal treatment of the hot-melt extrudates had a minimal effect on decreasing the drug release rate since the hot-melt extrusion process enhanced the entanglement of the drug and polymer to a greater extent. Drug release rates from both DTZ and CPM hot-melt extrudates increased with an increase in the TEC level in the formulations, while DTZ release from the EudragitRTM RS 30D coated pellets decreased with an increase of TEC in the coating layer. This could be attributed to the fact that a continuous polymeric structure was formed following hot-melt extrusion regardless of the TEC level. However, for the film coated pellets, coalescence of the polymer particles was enhanced with higher levels of TEC. Due to the lower solubility of IDM, no significant difference in drug release was observed in the IDM hot-melt extrudated granules containing 0%, 4%, and 8% TEC.
机译:该研究项目的目的是研究通过热熔挤出制备的包含高水溶性药物或水溶性差的药物的聚合物药物输送系统的物理化学和药物释放特性。通过热重分析(TGA),差示扫描量热法(DSC),稳定性指示RP-HPLC分析,溶出度研究,扫描电子显微镜(SEM),X射线衍射法,电子扭矩流变法,Zeta电位粒子表征了加工材料的性能尺寸分析和氦比重瓶。热熔挤出后,马来酸氯苯那敏(CPM),盐酸地尔硫卓(DTZ),消炎痛(IDM)和赋形剂是热稳定和化学稳定的。 CPM降低了EudragitRTM RS PO的玻璃化转变温度(Tg),并表现出固态增塑作用。经过热熔挤出加工后,CPM和IDM处于非晶态,而DTZ处于结晶态。柠檬酸三乙酯(TEC)通过降低EudragitRTM RS PO的Tg和熔体粘度来促进热熔挤出过程。但是,热润滑剂单硬脂酸甘油酯(GMS)仅降低Eudragit RTM RS PO的熔体粘度。从通过直接压片,热熔制粒和热熔挤出制备的片剂中,CPM释放速率常数按顺序降低。这是由于在热处理期间发生的药物分子与聚合物分子之间的分子间结合和缠结的增加。由于热熔挤出过程在更大程度上增强了药物和聚合物的缠结,因此热熔挤出物的后处理热处理对降低药物释放速率的影响很小。 DTZ和CPM热熔挤出物的药物释放速率均随着制剂中TEC含量的增加而增加,而EudragitRTM RS 30D包衣微丸的DTZ释放量随着涂层中TEC的增加而降低。这可以归因于这样的事实,即不管TEC含量如何,在热熔挤出后都形成了连续的聚合物结构。然而,对于薄膜包衣的粒料,随着更高含量的TEC,聚合物颗粒的聚结得以增强。由于IDM的溶解度较低,在含TEC为0%,4%和8%的IDM热熔挤出颗粒中,未观察到药物释放的显着差异。

著录项

  • 作者

    Zhu, Yucun.;

  • 作者单位

    The University of Texas at Austin.;

  • 授予单位 The University of Texas at Austin.;
  • 学科 Engineering Biomedical.; Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 245 p.
  • 总页数 245
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;药剂学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号